Company
Scynexis
Advancing innovative solutions for severe rare diseases
Also known as SCYNEXIS, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- SCYNEXIS, Inc.
- scynexis.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Committed to improving outcomes for patients living with severe, progressive, and underserved rare diseases.
Funding snapshot
- Total raised
- $40MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $40M2026-03-31
Funding rounds
- $40.0 Million Private Placement
- $40M2026-03-31, Company stated
- Round, 2011
- $11.4M2011-12-07, SEC form D sold, 11 investors
Products
- Other
- SCY-770
Loading relationship preview